|Articles|November 6, 2015
Patient Engagement & Rare Diseases Podcast
Author(s)DIA
Advertisement
Durhane Wong-Rieger, President & CEO of the Canadian Organization for Rare Disorders speaks with Global Forum Deputy Editor Alberto Grignolo about patient involvement and engagement, and the future of drug development for rare diseases on DIA’s podcast channel,
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Releases Updated Safety Data for Foundayo Following FDA’s Request
2
Johnson & Johnson’s Experience Navigating The Commissioner’s National Priority Voucher Program
3
How AI Is Transforming Drug Labeling
4
FDA’s Shift Signals a New Era for Data-Driven Drug Development
5